U.S. flag

An official website of the United States government

GRCh38/hg38 16p13.11-12.3(chr16:15261472-18768479)x3 AND See cases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 27, 2011
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000137451.5

Allele description [Variation Report for GRCh38/hg38 16p13.11-12.3(chr16:15261472-18768479)x3]

GRCh38/hg38 16p13.11-12.3(chr16:15261472-18768479)x3

Genes:
  • LOC130058560:ATAC-STARR-seq lymphoblastoid active region 10499 [Gene]
  • LOC130058561:ATAC-STARR-seq lymphoblastoid active region 10500 [Gene]
  • LOC130058562:ATAC-STARR-seq lymphoblastoid active region 10501 [Gene]
  • LOC130058563:ATAC-STARR-seq lymphoblastoid active region 10502 [Gene]
  • LOC130058564:ATAC-STARR-seq lymphoblastoid active region 10503 [Gene]
  • LOC130058565:ATAC-STARR-seq lymphoblastoid active region 10504 [Gene]
  • LOC130058566:ATAC-STARR-seq lymphoblastoid active region 10505 [Gene]
  • LOC130058568:ATAC-STARR-seq lymphoblastoid active region 10506 [Gene]
  • LOC130058569:ATAC-STARR-seq lymphoblastoid active region 10507 [Gene]
  • LOC130058570:ATAC-STARR-seq lymphoblastoid active region 10508 [Gene]
  • LOC130058572:ATAC-STARR-seq lymphoblastoid active region 10509 [Gene]
  • LOC130058573:ATAC-STARR-seq lymphoblastoid active region 10510 [Gene]
  • LOC130058574:ATAC-STARR-seq lymphoblastoid active region 10511 [Gene]
  • LOC130058575:ATAC-STARR-seq lymphoblastoid active region 10512 [Gene]
  • LOC130058576:ATAC-STARR-seq lymphoblastoid active region 10513 [Gene]
  • LOC130058577:ATAC-STARR-seq lymphoblastoid active region 10514 [Gene]
  • LOC130058578:ATAC-STARR-seq lymphoblastoid active region 10515 [Gene]
  • LOC130058579:ATAC-STARR-seq lymphoblastoid active region 10516 [Gene]
  • LOC130058580:ATAC-STARR-seq lymphoblastoid active region 10517 [Gene]
  • LOC130058567:ATAC-STARR-seq lymphoblastoid silent region 7235 [Gene]
  • LOC130058571:ATAC-STARR-seq lymphoblastoid silent region 7236 [Gene]
  • ABCC1:ATP binding cassette subfamily C member 1 (ABCC1 blood group) [Gene - OMIM - HGNC]
  • ABCC6:ATP binding cassette subfamily C member 6 [Gene - OMIM - HGNC]
  • LOC121587532:BRD4-independent group 4 enhancer GRCh37_chr16:15972689-15973888 [Gene]
  • LOC126862301:BRD4-independent group 4 enhancer GRCh37_chr16:17156208-17157407 [Gene]
  • LOC126862304:BRD4-independent group 4 enhancer GRCh37_chr16:17700860-17702059 [Gene]
  • LOC126862299:CDK7 strongly-dependent group 2 enhancer GRCh37_chr16:15693082-15694281 [Gene]
  • LOC126862302:CDK7 strongly-dependent group 2 enhancer GRCh37_chr16:17498817-17500016 [Gene]
  • LOC111365165:GATA motif-containing MPRA enhancer 79/80 [Gene]
  • LOC129390771:MPRA-validated peak2509 silencer [Gene]
  • LOC129390772:MPRA-validated peak2513 silencer [Gene]
  • MPV17L:MPV17 mitochondrial inner membrane protein like [Gene - OMIM - HGNC]
  • MPV17L-BMERB1:MPV17L-BMERB1 readthrough [Gene]
  • NOMO2:NODAL modulator 2 [Gene - OMIM - HGNC]
  • NOMO3:NODAL modulator 3 [Gene - OMIM - HGNC]
  • LOC126862298:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr16:15587399-15588598 [Gene]
  • LOC121847972:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr16:15684383-15685582 [Gene]
  • LOC126862300:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr16:15993095-15994294 [Gene]
  • LOC126862303:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr16:17665142-17666341 [Gene]
  • LOC126862305:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr16:17930405-17931604 [Gene]
  • LOC131696449:PKD1P1-NPIPA5L readthrough [Gene]
  • LOC121847973:Sharpr-MPRA regulatory region 10508 [Gene]
  • LOC112340385:Sharpr-MPRA regulatory region 10538 [Gene]
  • LOC112340383:Sharpr-MPRA regulatory region 11301 [Gene]
  • LOC112340381:Sharpr-MPRA regulatory region 12074 [Gene]
  • LOC112340379:Sharpr-MPRA regulatory region 1380 [Gene]
  • LOC125146421:Sharpr-MPRA regulatory region 15590 [Gene]
  • LOC112340382:Sharpr-MPRA regulatory region 4662 [Gene]
  • LOC113939949:Sharpr-MPRA regulatory region 5546 [Gene]
  • LOC125146419:Sharpr-MPRA regulatory region 7034 [Gene]
  • LOC125146420:Sharpr-MPRA regulatory region 7660 [Gene]
  • LOC112340380:Sharpr-MPRA regulatory region 9672 [Gene]
  • BMERB1:bMERB domain containing 1 [Gene - HGNC]
  • CEP20:centrosomal protein 20 [Gene - OMIM - HGNC]
  • MARF1:meiosis regulator and mRNA stability factor 1 [Gene - OMIM - HGNC]
  • MIR3179-2:microRNA 3179-2 [Gene - HGNC]
  • MIR3179-3:microRNA 3179-3 [Gene - HGNC]
  • MIR3179-4:microRNA 3179-4 [Gene - HGNC]
  • MIR3180-2:microRNA 3180-2 [Gene - HGNC]
  • MIR3180-3:microRNA 3180-3 [Gene - HGNC]
  • MIR3670-2:microRNA 3670-2 [Gene - HGNC]
  • MIR3670-3:microRNA 3670-3 [Gene - HGNC]
  • MIR3670-4:microRNA 3670-4 [Gene - HGNC]
  • MIR484:microRNA 484 [Gene - HGNC]
  • MIR6506:microRNA 6506 [Gene - HGNC]
  • MIR6511A2:microRNA 6511a-2 [Gene - HGNC]
  • MIR6511A3:microRNA 6511a-3 [Gene - HGNC]
  • MIR6511A4:microRNA 6511a-4 [Gene - HGNC]
  • MIR6770-2:microRNA 6770-2 [Gene - HGNC]
  • MIR6770-3:microRNA 6770-3 [Gene - HGNC]
  • MYH11:myosin heavy chain 11 [Gene - OMIM - HGNC]
  • NPIPA5:nuclear pore complex interacting protein family member A5 [Gene - HGNC]
  • NPIPA7:nuclear pore complex interacting protein family member A7 [Gene - HGNC]
  • NPIPA8:nuclear pore complex interacting protein family member A8 [Gene - HGNC]
  • NPIPA6:nuclear pore complex interacting protein family, member A6 [Gene - HGNC]
  • NPIPA9:nuclear pore complex interacting protein family, member A9 [Gene - HGNC]
  • NDE1:nudE neurodevelopment protein 1 [Gene - OMIM - HGNC]
  • LOC102723692:uncharacterized LOC102723692 [Gene]
  • XYLT1:xylosyltransferase 1 [Gene - OMIM - HGNC]
Variant type:
copy number gain
Cytogenetic location:
16p13.11-12.3
Genomic location:
Preferred name:
GRCh38/hg38 16p13.11-12.3(chr16:15261472-18768479)x3
HGVS:
  • NC_000016.10:g.(?_15261472)_(18768479_?)dup
  • NC_000016.8:g.(?_15262830)_(18687302_?)dup
  • NC_000016.9:g.(?_15355329)_(18779801_?)dup
Links:
dbVar: nssv1415300; dbVar: nsv817383
Observations:
1

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000177674ISCA site 1

See additional submitters

no assertion criteria provided
Uncertain significance
(Apr 27, 2011) 		maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]
PMID:
20466091
PMCID:
PMC2869000

Details of each submission

From ISCA site 1, SCV000177674.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: Sep 1, 2024